Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 32Myelodysplastic Syndromes 28Multiple Myeloma 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Hodgkin Disease 12Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11Lymphoma, Non-Hodgkin 10Lymphoma 10Hematologic Neoplasms 10Neuroblastoma 9Myeloproliferative Disorders 9Anemia, Refractory, with Excess of Blasts 8Lymphoma, Mantle-Cell 7Leukemia, Myelomonocytic, Chronic 7Leukemia 7Neoplasms, Plasma Cell 6Lymphoma, T-Cell 6Leukemia, Biphenotypic, Acute 6Graft vs Host Disease 6Leukemia, Lymphocytic, Chronic, B-Cell 5Burkitt Lymphoma 5Recurrence 4Primary Myelofibrosis 4Melanoma 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Leukemia, Myelomonocytic, Juvenile 4Hematologic Diseases 4Ganglioneuroblastoma 4Anemia, Aplastic 4

Interventions

Etoposide 3daratumumab 2Vincristine 2Prednisone 2Doxorubicin 2Cyclophosphamide 2varlilumab 1prednylidene 1pomalidomide 1deltacortene 1carmustine, poliferprosan 20 drug combination 1belantamab mafodotin 1Specimen Handling 1Rituximab 1Peripheral Blood Stem Cell Transplantation 1Nivolumab 1Melphalan 1Magnetic Resonance Spectroscopy 1Immunoglobulin G 1Disulfides 1Dexamethasone 1Cytarabine 1Carmustine 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Plasmablastic Lymphoma × Melphalan × 1 year × Clear all
NCT02797470 2026-05-18

Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant

AIDS Malignancy Consortium

Phase 1/2 Active not recruiting
11 enrolled 9 charts
Lymphoid

Plasmablastic Lymphoma, Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, HIV Infections, Lymphoma, T-Cell, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡